Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products
- 8 March 2022
- journal article
- review article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 194 (6) , 2831-2855
Abstract
Chronic elevation of sugar and oxidative stress generally results in development of advanced glycation end products (AGEs) in diabetic individuals. Accumulation of AGEs in an individual can give rise to the activation of several pathways that will ultimately lead to various complications. Such AGEs can also be prepared in an in vitro environment. For an in vitro preparation of advanced glycation end products (AGEs), proteins, lipids, or nucleic acids are generally required to be incubated with reducing sugars at a physiological temperature or higher depending upon the protocol optimized for its preparation. Certain other factors are also optimized and added to the buffer to hasten its preparation or alter the properties of prepared AGEs. Through this review, we intend to highlight the various studies related to the experimental procedures for the preparation of different types of AGEs. In addition, we present the comparative study of methodologies optimized for the preparation of AGEs.Keywords
Funding Information
- Ministry of Human Resource Development (ministry of human resource development)
This publication has 106 references indexed in Scilit:
- Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophreniaNeuropsychiatric Disease and Treatment, 2013
- Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stressBMC Cardiovascular Disorders, 2013
- Advanced glycation end productsDermato-Endocrinology, 2012
- AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathwayAutophagy, 2012
- Molecular Basis of Arterial Stiffening: Role of Glycation – A Mini-ReviewGerontology, 2012
- Advanced glycation end product level, diabetes, and accelerated cognitive agingNeurology, 2011
- Comparison of modification sites formed on human serum albumin at various stages of glycationClinica Chimica Acta, 2011
- Favored and disfavored pathways of protein crosslinking by glucose: glucose lysine dimer (GLUCOLD) and crossline versus glucosepaneAmino Acids, 2010
- Effect of glycation on α-crystallin structure and chaperone-like functionBiochemical Journal, 2007
- Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathwaysBone, 2007